Issued 2026-09-16 at $10.99 · now $10.99 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, NOMD has typically landed between $9.54 and $12.29 — a range of −13.2% to +11.8% from the issuance price $10.99.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
2,932 overlapping 1 month windows · 2014-09-09 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($10.99) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where NOMD has typically landed a month from the 2026-09-16 close of $10.99 — the range is history, not a prediction.
- now $10.99 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $10.93 (-0.6%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $10.32–$11.54
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $9.54–$12.29
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2016-01-12 | −46.3% | −46.3% | +0.0% |
| 2016-01-08 | −45.5% | −45.5% | +0.0% |
| 2016-01-11 | −43.7% | −45.5% | +0.0% |
| 3 best | |||
| 2015-03-24 | +82.4% | +0.0% | +82.4% |
| 2015-04-16 | +75.0% | +0.0% | +82.4% |
| 2015-04-15 | +75.0% | +0.0% | +82.4% |
2,932 overlapping windows · 2014-09-09 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~12 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-24 | BRISBY DOMINIC | director | Purchase | 50,000 @ $12.38 | $619K | +7.4% of holding | not yet — horizon still open | not yet — horizon still open | 726,794 | Form 4 · filed 2 days after the trade |
| 2026-08-19 | BALDEW RUBEN | director | Purchase | 28,290 @ $11.85 | $335K | +8.3% of holding | not yet — horizon still open | not yet — horizon still open | 367,172 | Form 4 · filed 2 days after the trade |
| 2026-05-15 | BRISBY DOMINIC | director | Purchase | 150,000 @ $9.79 | $1.5M | +28.5% of holding | +2.6% | not yet — horizon still open | 676,794 | Form 4 · filed 3 days after the trade |
| 2026-05-14 | BALDEW RUBEN | director | Purchase | 14,731 @ $9.71 | $143K | +4.5% of holding | +4.5% | not yet — horizon still open | 338,882 | Form 4 · filed 4 days after the trade |
| 2026-05-13 | ASHKEN IAN G H | director | Purchase | 100,000 @ $9.13 | $913K | +591.2% of holding | +14.8% | not yet — horizon still open | 116,916 | Form 4 · filed 2 days after the trade |
| 2026-05-12 | Gottesman Noam | director | Purchase | 200,000 @ $9.23 | $1.8M | +2.8% of holding | +12.6% | not yet — horizon still open | 7,408,560 | Form 4 · filed 1 day after the trade |
| 2026-05-11 | Gottesman Noam | director | Purchase | 500,000 @ $9.57 | $4.8M | +7.5% of holding | +12.7% | not yet — horizon still open | 7,208,560 | Form 4 · filed 2 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
16 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-02 | PARRY VICTORIA | director | Withheld for tax | 4,021 | 48,341 | Form 4 |
| 2026-07-02 | STACK MELANIE DAWN | director | Withheld for tax | 4,021 | 39,396 | Form 4 |
| 2026-07-02 | PILOWSKY AMIT | director | Withheld for tax | 3,729 | 35,464 | Form 4 |
| 2026-07-02 | LILLIE JAMES E | director | Withheld for tax | 3,580 | 689,386 | Form 4 |
| 2026-07-02 | Dorman Carey J. | director | Withheld for tax | 1,676 | 29,356 | Form 4 |
| 2026-06-22 | PARRY VICTORIA | director | Award / grant | 13,972 | 52,362 | Form 4 |
| 2026-06-22 | PILOWSKY AMIT | director | Award / grant | 21,656 | 39,193 | Form 4 |
| 2026-06-22 | STACK MELANIE DAWN | director | Award / grant | 21,856 | 43,417 | Form 4 |
| 2026-06-22 | LILLIE JAMES E | director | Award / grant | 13,972 | 692,966 | Form 4 |
| 2026-06-22 | Dorman Carey J. | director | Award / grant | 22,654 | 31,032 | Form 4 |
| 2026-05-07 | Gottesman Noam | director | Award / grant | 1,000,000 | 1,000,000 | Form 4 |
| 2026-05-07 | FRANKLIN MARTIN E | director | Award / grant | 1,000,000 | 1,000,000 | Form 4 |
| 2026-05-07 | BRISBY DOMINIC | director | Award / grant | 5,000,000 | 5,000,000 | Form 4 |
| 2026-05-07 | BALDEW RUBEN | director | Award / grant | 1,850,000 | 1,850,000 | Form 4 |
| 2026-05-06 | FRANKLIN MARTIN E | director | Other acquisition | 220,000 | 7,442,212 | Form 4 |
| 2026-05-06 | FRANKLIN MARTIN E | director | Other acquisition | 220,000 | 3,321,251 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.